Heart Failure Drug Management Tips and Tricks: The Foundational Four and Backup Plans

Ileana L. Piña, MD, MPH; Carolyn Lam, MBBS, PhD

September 29, 2021

This transcript has been edited for clarity.

Ileana L. Piña, MD, MPH: Hello. I'm Ileana Piña from Central Michigan University in Michigan, and an adjunct professor of epidemiology and biostatistics at Case Western Reserve University. This is my blog.

This is our third conversation this year at the European Society of Cardiology (ESC) Congress, which is being held in Amsterdam. This is a terrific meeting that many of us have attended in the past because we start to see the new stuff coming out. The late-breaking trials are always exciting, and they usually get published at the same time. This year, we have a richness of heart failure stuff. We're going to have to decide how we're going to apply all this to that patient who's sitting in front of us in clinic.

With me today is a very dear friend, Dr Carolyn Lam from Singapore. Carolyn is a professor at the Duke University Singapore and a consultant for the National Institutes of Health. She spent time in Framingham and has been a spokesperson for Framingham, and I've heard her deliver some beautiful lectures on things like pulmonary hypertension.

Carolyn Lam, MBBS, PhD:Ileana, you've forgotten my most important title.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.